Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-13

Clinical Trial Update: Comparison of Efficacy of 5% Fluorocalcium Phosphosilicate Dentifrice and Potassium Nitrate Dentifrice on Dentinal Hypersensitivity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing 5% fluorocalcium phosphosilicate dentifrice to potassium nitrate dentifrice for dentinal hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5% fluorocalcium phosphosilicate dentifrice
  • potassium nitrate dentifrice

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Dentinal Hypersensitivity | Phase 2 | Status: COMPLETED